{"transactions":[{"id":1308015,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-07T22:20:23.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":6502,"price":12.18,"value":79194.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2025, and does not represent a volitional trade by the Reporting Person."}],"balance_after":59878,"source":{"system":"sec-edgar","filing":"0000950170-25-003014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017025003014/ownership.xml","form_type":"4"}},{"id":1596207,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-05T21:10:17.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":42421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":42421,"derivative":{"exercise_price":32.66,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":42421},"source":{"system":"sec-edgar","filing":"0000950170-24-025903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024025903/ownership.xml","form_type":"4"}},{"id":1596206,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-03-05T21:10:17.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":29393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":66380,"source":{"system":"sec-edgar","filing":"0000950170-24-025903","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024025903/ownership.xml","form_type":"4"}},{"id":1685481,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-01-05T21:46:39.000Z","date":"2024-01-03","kind":"sale","planned":false,"acquired":false,"shares":3877,"price":29.46,"value":114216.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory \"sell-to-cover\" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1 and January 3, 2024, and does not represent a volitional trade by the Reporting Person."}],"balance_after":36987,"source":{"system":"sec-edgar","filing":"0000950170-24-002507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000095017024002507/ownership.xml","form_type":"4"}},{"id":1973482,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-03-03T22:31:40.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":33287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 1, 2023 with respect to shares of Common Stock, with 33% vesting on January 1, 2024 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter."}],"balance_after":33287,"derivative":{"exercise_price":40.75,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":33287},"source":{"system":"sec-edgar","filing":"0001209191-23-015817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123015817/doc4.xml","form_type":"4"}},{"id":1973481,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:31:40.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":23558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":40864,"source":{"system":"sec-edgar","filing":"0001209191-23-015817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123015817/doc4.xml","form_type":"4"}},{"id":2060423,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-01-06T22:29:43.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":1812,"price":37.21,"value":67424.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 3, 2023."}],"balance_after":17306,"source":{"system":"sec-edgar","filing":"0001209191-23-002421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919123002421/doc4.xml","form_type":"4"}},{"id":2443946,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-01-05T21:15:28.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2022 with respect to 25,000 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 25% vesting on December 20, 2022 and the remaining 75% vesting in thirty-six (36) substantially equal monthly installments thereafter."}],"balance_after":25000,"derivative":{"exercise_price":118.99,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-001651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122001651/doc4.xml","form_type":"4"}},{"id":2443945,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":84337,"kind":"person","name":"Hicks Derek","position":1,"cik":"0001901282","reported_name":"Hicks Derek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-01-05T21:15:28.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":19118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit."}],"balance_after":19118,"source":{"system":"sec-edgar","filing":"0001209191-22-001651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000120919122001651/doc4.xml","form_type":"4"}}]}